G 531
Pill imprint G 531 has been identified as Bendroflumethiazide and nadolol 5 mg / 40 mg.
Bendroflumethiazide/nadolol is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy.
Bendroflumethiazide/nadolol 5 mg / 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Bendroflumethiazide and nadolol Images
- Imprint:
-
G 531
- Strength:
- 5 mg / 40 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromellose 2910
lactose monohydrate
magnesium stearate
mannitol
microcrystalline cellulose
pregelatinized starch
magnesium silicate
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-5311
Advertisement
More Bendroflumethiazide and Nadolol resources
- Bendroflumethiazide/Nadolol (Wolters Kluwer)
- bendroflumethiazide and nadolol (Cerner Multum)
- nadolol and bendroflumethiazide (Micromedex) - Includes Dosage Information
- Nadolol and Bendroflumethiazide (FDA)
Search Again
